Genopathomic profiling identifies signatures for immunotherapy response of lung adenocarcinoma via confounder-aware representation learning

Bibliographic Details
Title: Genopathomic profiling identifies signatures for immunotherapy response of lung adenocarcinoma via confounder-aware representation learning
Authors: Jiajun Deng, Jiancheng Yang, Likun Hou, Junqi Wu, Yi He, Mengmeng Zhao, Bingbing Ni, Donglai Wei, Hanspeter Pfister, Caicun Zhou, Tao Jiang, Yunlang She, Chunyan Wu, Chang Chen
Source: iScience, Vol 25, Iss 11, Pp 105382- (2022)
Publisher Information: Elsevier, 2022.
Publication Year: 2022
Collection: LCC:Science
Subject Terms: Immunology, Cancer, Artificial intelligence, Science
More Details: Summary: Immunotherapy shows durable response but only in a subset of patients, and test for predictive biomarkers requires procedures in addition to routine workflow. We proposed a confounder-aware representation learning-based system, genopathomic biomarker for immunotherapy response (PITER), that uses only diagnosis-acquired hematoxylin-eosin (H&E)-stained pathological slides by leveraging histopathological and genetic characteristics to identify candidates for immunotherapy. PITER was generated and tested with three datasets containing 1944 slides of 1239 patients. PITER was found to be a useful biomarker to identify patients of lung adenocarcinoma with both favorable progression-free and overall survival in the immunotherapy cohort (p
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2589-0042
Relation: http://www.sciencedirect.com/science/article/pii/S2589004222016546; https://doaj.org/toc/2589-0042
DOI: 10.1016/j.isci.2022.105382
Access URL: https://doaj.org/article/0e697dab45a44642aec9804adb7a7dd5
Accession Number: edsdoj.0e697dab45a44642aec9804adb7a7dd5
Database: Directory of Open Access Journals
More Details
ISSN:25890042
DOI:10.1016/j.isci.2022.105382
Published in:iScience
Language:English